Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 PolynovoConcordia InternationalClinuvel PharmaceuticalsMesoblastResverlogix
SymbolASX:PNVN/AASX:CUVASX:MSBTSE:RVX
Price Information
Current PriceA$2.24N/AA$25.54A$2.02C$2.54
52 Week RangeN/AN/AN/AN/ABuy
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/ABuy
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$1.48 billionC$1.22 billion$1.25 billion$1.00 billionC$531.25 million
BetaN/AN/AN/AN/AN/A
Average VolumeN/A4,054N/A2,190,00083,050
Sales & Book Value
Annual Revenue$14.04 millionC$569.62 million$31.05 million$16.72 millionN/A
Price / Sales105.440.0040.2859.81N/A
CashflowA$0.02 per shareN/AA$1.19 per shareA$0.10 per shareC$0.04 per share
Price / Cash100.005.8521.4419.8071.05
Book ValueA$0.04 per shareC$6.08 per shareA$1.17 per shareA$0.97 per shareC($1.04) per share
Price / Book57.440.0021.872.08N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSA($0.01)C$351.68A$0.37A($0.18)C($0.87)
Trailing P/E RatioN/A0.0769.78N/AN/A
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AA$20.71N/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AA$0.03N/AN/A
Dividend YieldN/AN/A0.12%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/A8.20%N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A457.02%0.76%16.90%N/A
Current Ratio9.64%2.10%12.33%1.41%0.12%
Quick Ratio8.90%1.66%11.78%1.21%0.10%
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees41N/AN/A81N/A
Shares Outstanding661.09 million48.91 million48.96 million495.13 million209.15 million
Next Earnings DateN/AN/AN/A11/15/2019 (Estimated)12/12/2019 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
 PolynovoConcordia InternationalClinuvel PharmaceuticalsMesoblastResverlogix

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel